HEADER HYDROLASE 27-FEB-98 3GCB TITLE GAL6 (YEAST BLEOMYCIN HYDROLASE) MUTANT C73A/DELTAK454 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAL6; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: YBH, YEAST BLEOMYCIN HYDROLASE; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 CELL_LINE: BL21; SOURCE 6 GENE: GAL6C73ADELK; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PKM260/PLYSS; SOURCE 11 EXPRESSION_SYSTEM_GENE: GAL6C73ADELK KEYWDS BLEOMYCIN HYDROLASE, PEPTIDASE, PROTEASE, DNA-BINDING PROTEIN, SELF- KEYWDS 2 COMPARTMENTALIZING PROTEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.JOSHUA-TOR,W.ZHENG,S.A.JOHNSTON REVDAT 6 22-MAY-24 3GCB 1 REMARK REVDAT 5 09-AUG-23 3GCB 1 REMARK REVDAT 4 03-NOV-21 3GCB 1 REMARK SEQADV REVDAT 3 13-JUL-11 3GCB 1 VERSN REVDAT 2 24-FEB-09 3GCB 1 VERSN REVDAT 1 21-OCT-98 3GCB 0 JRNL AUTH W.ZHENG,S.A.JOHNSTON,L.JOSHUA-TOR JRNL TITL THE UNUSUAL ACTIVE SITE OF GAL6/BLEOMYCIN HYDROLASE CAN ACT JRNL TITL 2 AS A CARBOXYPEPTIDASE, AMINOPEPTIDASE, AND PEPTIDE LIGASE. JRNL REF CELL(CAMBRIDGE,MASS.) V. 93 103 1998 JRNL REFN ISSN 0092-8674 JRNL PMID 9546396 JRNL DOI 10.1016/S0092-8674(00)81150-2 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.JOSHUA-TOR,H.E.XU,S.A.JOHNSTON,D.C.REES REMARK 1 TITL CRYSTAL STRUCTURE OF A CONSERVED PROTEASE THAT BINDS DNA: REMARK 1 TITL 2 THE BLEOMYCIN HYDROLASE, GAL6 REMARK 1 REF SCIENCE V. 269 945 1995 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 48446 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4876 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.87 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4149 REMARK 3 BIN R VALUE (WORKING SET) : 0.1980 REMARK 3 BIN FREE R VALUE : 0.2280 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 472 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3694 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 421 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.310 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.500 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.000 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX_JPL.PRO REMARK 3 PARAMETER FILE 2 : PARAM19_LJ.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX_JPL.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19_MOD.SOL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 40 PROTEIN ATOMS WITH 0 OCCUPANCY BECAUSE OF DISORDERED SIDE CHAINS REMARK 3 REMARK 3 OCCUPANCIES FOR 40 PROTEIN ATOMS WERE SET TO 0.0 BECAUSE OF REMARK 3 DISORDERED SIDE CHAINS. 5 OF THE 17 RESIDUE HIS-TAG/TEV REMARK 3 SITE ARE SEEN IN THE STRUCTURE. REMARK 4 REMARK 4 3GCB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178978. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : SEP-96 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49450 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : 0.04200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 39.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.06200 REMARK 200 R SYM FOR SHELL (I) : 0.06200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 22.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1GCB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM AMMONIUM REMARK 280 SULFATE AND PEG MME 2K., PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z REMARK 290 10555 -Y,-X,-Z+1/2 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 45.06700 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 45.06700 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 45.06700 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 45.06700 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 45.06700 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 45.06700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 44040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 99330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -540.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 150.54700 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 75.27350 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 130.37753 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.500000 -0.866025 0.000000 75.27350 REMARK 350 BIOMT2 4 -0.866025 -0.500000 0.000000 130.37753 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 45.06700 REMARK 350 BIOMT1 5 -1.000000 0.000000 0.000000 150.54700 REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 45.06700 REMARK 350 BIOMT1 6 0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 45.06700 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 ALA A -9 REMARK 465 SER A -8 REMARK 465 GLU A -7 REMARK 465 ASN A -6 REMARK 465 LEU A -5 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ALA A -4 N CA CB REMARK 480 MET A 1 SD CE REMARK 480 LYS A 47 CE NZ REMARK 480 ARG A 174 NE CZ NH1 NH2 REMARK 480 LYS A 196 CD CE NZ REMARK 480 GLU A 197 CG CD OE1 OE2 REMARK 480 LYS A 281 NZ REMARK 480 LYS A 309 CG CD CE NZ REMARK 480 LYS A 334 CE NZ REMARK 480 LYS A 383 CB CG CD CE NZ REMARK 480 ASN A 423 OD1 ND2 REMARK 480 LYS A 427 CD CE NZ REMARK 480 LYS A 437 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 438 N - CA - C ANGL. DEV. = -23.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 68 -146.29 57.30 REMARK 500 TYR A 163 101.45 -168.41 REMARK 500 ASP A 165 36.90 -86.61 REMARK 500 ALA A 172 74.55 -158.04 REMARK 500 ARG A 287 -29.21 61.52 REMARK 500 ASN A 290 -56.85 -137.10 REMARK 500 PHE A 416 -48.55 -139.99 REMARK 500 SER A 435 -81.03 -45.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: A73 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NUCLEOPHILIC CYSTEINE MUTATED TO ALANINE. REMARK 800 REMARK 800 SITE_IDENTIFIER: NUL REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC RESIDUES. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1002 DBREF 3GCB A 3 453 UNP Q01532 BLH1_YEAST 3 453 SEQADV 3GCB ALA A 73 UNP Q01532 CYS 73 ENGINEERED MUTATION SEQRES 1 A 470 MET HIS HIS HIS HIS HIS HIS ALA SER GLU ASN LEU ALA SEQRES 2 A 470 PHE GLN GLY ALA MET ALA SER SER ILE ASP ILE SER LYS SEQRES 3 A 470 ILE ASN SER TRP ASN LYS GLU PHE GLN SER ASP LEU THR SEQRES 4 A 470 HIS GLN LEU ALA THR THR VAL LEU LYS ASN TYR ASN ALA SEQRES 5 A 470 ASP ASP ALA LEU LEU ASN LYS THR ARG LEU GLN LYS GLN SEQRES 6 A 470 ASP ASN ARG VAL PHE ASN THR VAL VAL SER THR ASP SER SEQRES 7 A 470 THR PRO VAL THR ASN GLN LYS SER SER GLY ARG ALA TRP SEQRES 8 A 470 LEU PHE ALA ALA THR ASN GLN LEU ARG LEU ASN VAL LEU SEQRES 9 A 470 SER GLU LEU ASN LEU LYS GLU PHE GLU LEU SER GLN ALA SEQRES 10 A 470 TYR LEU PHE PHE TYR ASP LYS LEU GLU LYS ALA ASN TYR SEQRES 11 A 470 PHE LEU ASP GLN ILE VAL SER SER ALA ASP GLN ASP ILE SEQRES 12 A 470 ASP SER ARG LEU VAL GLN TYR LEU LEU ALA ALA PRO THR SEQRES 13 A 470 GLU ASP GLY GLY GLN TYR SER MET PHE LEU ASN LEU VAL SEQRES 14 A 470 LYS LYS TYR GLY LEU ILE PRO LYS ASP LEU TYR GLY ASP SEQRES 15 A 470 LEU PRO TYR SER THR THR ALA SER ARG LYS TRP ASN SER SEQRES 16 A 470 LEU LEU THR THR LYS LEU ARG GLU PHE ALA GLU THR LEU SEQRES 17 A 470 ARG THR ALA LEU LYS GLU ARG SER ALA ASP ASP SER ILE SEQRES 18 A 470 ILE VAL THR LEU ARG GLU GLN MET GLN ARG GLU ILE PHE SEQRES 19 A 470 ARG LEU MET SER LEU PHE MET ASP ILE PRO PRO VAL GLN SEQRES 20 A 470 PRO ASN GLU GLN PHE THR TRP GLU TYR VAL ASP LYS ASP SEQRES 21 A 470 LYS LYS ILE HIS THR ILE LYS SER THR PRO LEU GLU PHE SEQRES 22 A 470 ALA SER LYS TYR ALA LYS LEU ASP PRO SER THR PRO VAL SEQRES 23 A 470 SER LEU ILE ASN ASP PRO ARG HIS PRO TYR GLY LYS LEU SEQRES 24 A 470 ILE LYS ILE ASP ARG LEU GLY ASN VAL LEU GLY GLY ASP SEQRES 25 A 470 ALA VAL ILE TYR LEU ASN VAL ASP ASN GLU THR LEU SER SEQRES 26 A 470 LYS LEU VAL VAL LYS ARG LEU GLN ASN ASN LYS ALA VAL SEQRES 27 A 470 PHE PHE GLY SER HIS THR PRO LYS PHE MET ASP LYS LYS SEQRES 28 A 470 THR GLY VAL MET ASP ILE GLU LEU TRP ASN TYR PRO ALA SEQRES 29 A 470 ILE GLY TYR ASN LEU PRO GLN GLN LYS ALA SER ARG ILE SEQRES 30 A 470 ARG TYR HIS GLU SER LEU MET THR HIS ALA MET LEU ILE SEQRES 31 A 470 THR GLY CYS HIS VAL ASP GLU THR SER LYS LEU PRO LEU SEQRES 32 A 470 ARG TYR ARG VAL GLU ASN SER TRP GLY LYS ASP SER GLY SEQRES 33 A 470 LYS ASP GLY LEU TYR VAL MET THR GLN LYS TYR PHE GLU SEQRES 34 A 470 GLU TYR CYS PHE GLN ILE VAL VAL ASP ILE ASN GLU LEU SEQRES 35 A 470 PRO LYS GLU LEU ALA SER LYS PHE THR SER GLY LYS GLU SEQRES 36 A 470 GLU PRO ILE VAL LEU PRO ILE TRP ASP PRO MET GLY ALA SEQRES 37 A 470 LEU ALA HET SO4 A1101 5 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET SO4 A1105 5 HET GOL A1001 6 HET GOL A1002 6 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 SO4 5(O4 S 2-) FORMUL 7 GOL 2(C3 H8 O3) FORMUL 9 HOH *421(H2 O) HELIX 1 1 PHE A -3 ALA A 2 1 6 HELIX 2 2 ILE A 7 SER A 19 1 13 HELIX 3 3 LEU A 21 LEU A 30 1 10 HELIX 4 4 ALA A 35 LEU A 39 1 5 HELIX 5 5 LYS A 42 GLN A 48 1 7 HELIX 6 6 ALA A 73 GLU A 89 1 17 HELIX 7 7 GLN A 99 SER A 120 1 22 HELIX 8 8 ARG A 129 ALA A 136 1 8 HELIX 9 9 TYR A 145 TYR A 155 1 11 HELIX 10 10 LYS A 160 LEU A 162 5 3 HELIX 11 11 TYR A 168 THR A 171 1 4 HELIX 12 12 ARG A 174 GLU A 197 1 24 HELIX 13 13 SER A 203 PHE A 223 1 21 HELIX 14 14 PRO A 253 LYS A 259 1 7 HELIX 15 15 ASN A 304 GLN A 316 1 13 HELIX 16 16 TYR A 345 ILE A 348 5 4 HELIX 17 17 LYS A 356 ARG A 361 1 6 HELIX 18 18 GLN A 408 TYR A 414 1 7 HELIX 19 19 ILE A 422 GLU A 424 5 3 HELIX 20 20 LYS A 427 THR A 434 1 8 SHEET 1 A 2 GLN A 234 VAL A 240 0 SHEET 2 A 2 ILE A 246 THR A 252 -1 N SER A 251 O PHE A 235 SHEET 1 B 9 ILE A 441 LEU A 443 0 SHEET 2 B 9 LEU A 282 ILE A 285 1 N LYS A 284 O ILE A 441 SHEET 3 B 9 VAL A 297 ASN A 301 -1 N TYR A 299 O ILE A 283 SHEET 4 B 9 PRO A 268 ILE A 272 1 N SER A 270 O LEU A 300 SHEET 5 B 9 CYS A 415 ASP A 421 -1 N VAL A 420 O VAL A 269 SHEET 6 B 9 VAL A 321 SER A 325 -1 N GLY A 324 O PHE A 416 SHEET 7 B 9 HIS A 369 HIS A 377 -1 N ILE A 373 O VAL A 321 SHEET 8 B 9 ARG A 387 GLU A 391 -1 N GLU A 391 O LEU A 372 SHEET 9 B 9 LEU A 403 THR A 407 -1 N MET A 406 O TYR A 388 CISPEP 1 THR A 62 PRO A 63 0 -1.09 CISPEP 2 THR A 327 PRO A 328 0 -2.35 SITE 1 A73 1 ALA A 73 SITE 1 NUL 2 HIS A 369 ASN A 392 SITE 1 AC1 6 ASN A 66 GLY A 395 LYS A 396 HOH A 812 SITE 2 AC1 6 HOH A 857 HOH A 907 SITE 1 AC2 5 ILE A 126 ARG A 192 TYR A 362 HOH A 566 SITE 2 AC2 5 HOH A 632 SITE 1 AC3 6 ASN A 273 TYR A 279 ASP A 303 ASN A 304 SITE 2 AC3 6 HOH A 550 HOH A 639 SITE 1 AC4 4 LYS A 175 SER A 178 LYS A 329 HOH A 543 SITE 1 AC5 4 ARG A 44 GLU A 341 HOH A 677 HOH A 678 SITE 1 AC6 9 GLN A 81 LEU A 82 ASN A 85 LYS A 262 SITE 2 AC6 9 ARG A 314 LYS A 319 ASP A 421 HOH A 595 SITE 3 AC6 9 HOH A 753 SITE 1 AC7 6 ARG A 129 GLN A 132 TYR A 133 TRP A 446 SITE 2 AC7 6 HOH A 780 HOH A 783 CRYST1 150.547 150.547 90.134 90.00 90.00 120.00 P 63 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006642 0.003835 0.000000 0.00000 SCALE2 0.000000 0.007670 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011095 0.00000